Kabi Is Ready To Get More Aggressive On US Market Share

 
• By Aidan Fry
  
Chocolate_Cake
Fresenius Kabi is ready to act aggressively to defend its share of the US intravenous generics market • Source: Shutterstock

More from Drug Pricing

More from Policy & Regulation